These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31493715)

  • 1. Functioning and cognitive characteristics of clozapine users referred to psychosocial rehabilitation centers: A REHABase cohort study.
    Verdoux H; Quiles C; Cervello S; Dubreucq J; Bon L; Massoubre C; Pommier R; Legros-Lafarge E; Jaafari N; Guillard-Bouhet N; Chéreau-Boudet I; Couhet G; Plasse J; Franck N
    Psychiatry Res; 2019 Nov; 281():112543. PubMed ID: 31493715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia.
    Manschreck TC; Redmond DA; Candela SF; Maher BA
    J Neuropsychiatry Clin Neurosci; 1999; 11(4):481-9. PubMed ID: 10570762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.
    Sharma T; Hughes C; Soni W; Kumari V
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):398-403. PubMed ID: 12845415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of anticholinergic load on functioning and cognitive performances of persons with psychosis referred to psychosocial rehabilitation centers.
    Verdoux H; Quiles C; Bon L; Chéreau-Boudet I; Dubreucq J; Fiegi L; Guillard-Bouhet N; Massoubre C; Plasse J; Franck N
    Psychol Med; 2021 Dec; 51(16):2789-2797. PubMed ID: 32441236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine and Psychosocial Function in Schizophrenia: A Systematic Review and Meta-Analysis.
    Olagunju AT; Clark SR; Baune BT
    CNS Drugs; 2018 Nov; 32(11):1011-1023. PubMed ID: 30155842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics.
    Han M; Zhang XY; Chen DC; Tan YL; Song CS; Yu YH; Huang XF
    Int Clin Psychopharmacol; 2015 Mar; 30(2):89-95. PubMed ID: 25568968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI; Czobor P; Nolan KA
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials.
    Nielsen RE; Levander S; Kjaersdam Telléus G; Jensen SO; Østergaard Christensen T; Leucht S
    Acta Psychiatr Scand; 2015 Mar; 131(3):185-96. PubMed ID: 25597383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
    Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M
    J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
    Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ
    Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of galantamine added to clozapine on cognition of five patients with schizophrenia.
    Bora E; Veznedaroğlu B; Kayahan B
    Clin Neuropharmacol; 2005; 28(3):139-41. PubMed ID: 15965314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?
    Anderson VM; McIlwain ME; Kydd RR; Russell BR
    Psychiatry Res; 2015 Dec; 230(3):811-8. PubMed ID: 26564550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
    Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
    Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
    Kaneda Y; Jayathilak K; Meltzer H
    Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.
    Harvey PD; Sacchetti E; Galluzzo A; Romeo F; Gorini B; Bilder RM; Loebel AD
    Schizophr Res; 2008 Oct; 105(1-3):138-43. PubMed ID: 18077136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia.
    McArdle PA; De Mel V; DeMonte V; Winckel K; Gore-Jones V; Foley S; Korman N; Parker S; Dark F; Siskind D
    Schizophr Res; 2019 Apr; 206():450-451. PubMed ID: 30527271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.